Log on / register
Feedback | Support | My details
Phosphoenolpyruvate carboxykinase and the critical role of cataplerosis in the control of hepatic metabolism.
Hakimi P, Johnson MT, Yang J, Lepage DF, Conlon RA, Kalhan SC, Reshef L, Tilghman SM, Hanson RW
Nutr Metab (Lond) 2005, 2:33
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice.
Gómez-Valadés AG, Méndez-Lucas A, Vidal-Alabró A, Blasco FX, Chillon M, Bartrons R, Bermúdez J, Perales JC
Diabetes 2008 Aug, 57:2199-210
[PubMed Central] [PubMed] [Related articles]

2.
Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver.
Burgess SC, He T, Yan Z, Lindner J, Sherry AD, Malloy CR, Browning JD, Magnuson MA
Cell Metab 2007 Apr, 5:313-20
[PubMed Central] [PubMed] [Related articles]

3.
Alterations in hepatic glucose and energy metabolism as a result of calorie and carbohydrate restriction.
Browning JD, Weis B, Davis J, Satapati S, Merritt M, Malloy CR, Burgess SC
Hepatology 2008 Nov, 48:1487-96
[PubMed Central] [PubMed] [Related articles]

printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.